Revelation Biosciences, Inc. Common Stock (REVB) Stock Price, Quote & AI Analysis

Live REVB stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for Revelation Biosciences, Inc. Common Stock.

TradeVae provides AI-driven analysis and real-time market intelligence for Revelation Biosciences, Inc. Common Stock (REVB), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.

REVB
Revelation Biosciences, Inc. Common Stock
real-time
$0.00 +0.00 (+0.00%)
Open
1.910000
High
1.960000
Low
1.810000
Volume
99,984
VWAP
-
Market Cap
$3,095,361.06
52W Range
$1.78 - $55.20
P/E Ratio
-
EPS
-
Debt/Equity
-
EV/EBITDA
-
Upcoming Earnings
Mar 4, 2026 Q4
After Hours
EPS Estimate: $-0.9333
Loading chart...

AI Analysis

Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.

Loading...

Generating AI analysis...

-
-
-
-

Revelation Biosciences, Inc. Common Stock's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.

Revelation Biosciences, Inc. Common Stock Overview

Company information

Company Overview

Revelation Biosciences, Inc. is a clinical-stage life sciences company, which focuses on the development of immunologic-based therapies for the prevention and treatment of disease. Its product candidates include REVTx-99b, its lead therapeutic candidate being developed for allergic rhinitis and chronic nasal congestion, REVDx 501, a rapid home use diagnostic that can be used to detect any respiratory viral infection, regardless of virus type or strain, without the need for specialized instrumentation, and REVTx 200, an intranasal immunomodulator adjunct to be used in combination with an intramuscular vaccination for more complete immunity. The company was founded on November 20, 2019 and is headquartered in San Diego, CA.

Company Details
Market Cap
$2.96M
Shares Outstanding
1,583,951
Weighted Shares Outstanding
1,481,034
CEO
James M. Rolke
Address
4660 LAJOLLA VILLAGE DRIVE, SAN DIEGO, CA, 92122
Employees
9
Industry
PHARMACEUTICAL PREPARATIONS
Exchange
XNAS

Technical Indicators

Key technical analysis metrics and signals

Loading...

Loading technical indicators...

Valuation Metrics

Key valuation ratios and comparisons

Loading...

Loading valuation metrics...

Revelation Biosciences, Inc. Common Stock Earnings & Financial Statements

Earnings Calendar

Upcoming earnings dates and historical surprises

Loading...

Loading earnings calendar...

Financial Statements

Income statements, balance sheets, and cash flow

Loading...

Loading income statements...

Loading...

Loading balance sheets...

Loading...

Loading cash flow statements...